Choline transport for phospholipid synthesis

Experimental Biology and Medicine

Volumn 231, Issue 5, 2006, Pages 490-504

  Michel, Vera ^a   Yuan, Zongfei ^a   Ramsubir, Shobha ^b   Bakovic, Marica ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Choline; Choline transport; CTL1; Phospholipids

Indexed keywords

CARRIER PROTEIN; CHOLINE; CHOLINE TRANSPORTER; CHT1 PROTEIN, HUMAN; CTL1 PROTEIN, HUMAN; CTL1 PROTEIN, MOUSE; ISOPROTEIN; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; PHOSPHOLIPID;

AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL LINE; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW; SEQUENCE ALIGNMENT; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CHOLINE; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; PHOSPHOLIPIDS; PROTEIN CONFORMATION; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT;

EID: 33744970494     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100503     Document Type: Short Survey

References (164)

1. Blusztajn JK. Developmental neuroscience: enhanced choline, a vital amine. Science 281:794-795, 1998.
2. Sheard NF, Zeisel SH. Choline: an essential dietary nutrient? Nutrition 5:1-5, 1989.
3. Sweet DH, Miller DS, Pritchard JB. Ventricular choline transport - a role for organic cation transporter 2 expressed in choroids plexus. J Biol Chem 276:41611-416119, 2001.
4. Zeisel SH, da Costa KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A. Choline: an essential nutrient for humans. FASEB J 5:2093-2098, 1991.
5. Zeisel SH. Choline: essential for brain development and function. Adv Pediatr 44:263-295, 1997.
6. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 14:269-296, 1994.
7. Fisher MC, Zeisel SH, Mar MH, Sadler TW. Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology 64:114-122, 2001.
8. Blusztajn JK, Wurtman RJ. Choline and cholinergic neurons. Science 221:614-620, 1983.
9. Wessler I, Kilbinger H, Bittenger F, Kirkpatrick CJ. The biological role of non-neuronal acetylcholine in plants and humans. J Pharmacol 85:2-10, 2001.
10. Wessler I, Kirkpatrick CJ, Racké K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77:59-79, 1998.
11. Institute of Medicine and National Academy of Sciences of the USA. Dietary Reference Intakes for Folate, Thiamin, Riboflavin, Niacin, Vitamin B12, Panthothenic Acid, Biotin, and Choline. Washington, DC: National Academic Press, Vol. 1:390-422, 1998.
12. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 133: 1302-1307, 2003.
13. Yang Y, Liu Z, Cermak JM, Tandon P, Sarkisian MR, Stafstrom CE, Neill JC, Blusztajn JK, Holmes GL. Protective effects of prenatal choline supplementation on seizure-induced memory impairment. J Neurosci 20:1-6, 2000.
14. Garner SC, Mar MH, Zeisel SH. Choline distribution and metabolism in pregnant rats and fetuses are influenced by the choline content of the maternal diet. J Nutr 125:2851-2858, 1995.
15. Cermak JM, Blusztajn JK, Meck WH, Williams CL, Fitzgerald CM, Rosene DL, Loy R. Prenatal availability of choline alters the development of acetylcholinesterase in the rat hippocampus. Dev Neurosci 21:94-104, 1999.
16. Fischer LM, Scearce JA, Mar MH, Patel JR, Blanchard RT, Macintosh BA, Busby MG, Zeisel SH. Ad libitum choline intake in healthy individuals meets or exceeds the proposed adequate intake level. J Nutr 135:826-829, 2005.
17. Zeisel SH. Choline, homocysteine and pregnancy. Am J Clin Nutr 82: 719-720, 2005.
18. Zeisel SH. Choline: an essential nutrient for humans. Nutrition 16: 669-671, 2000.
19. Zeisel SH. Choline: a nutrient that is involved in the regulation of cell proliferation, cell death, and cell transformation. In: Heber D, Kritchevsky D, eds. Dietary Fats, Lipids, Hormones and Tumorigenesis. New York: Plenum Press, pp131-141, 1996.
20. Albright CD, Liu R, Bethea TC, Da Costa KA, Salganik RI, Zeisel SH. Choline deficiency induces apoptosis in SV-40 immortalized CWSV-1 rat hepatocytes in culture. FASEB J 10:510-516, 1996.
21. Zeisel SH, Albright CD, Shin OH, Mar MH, Salganik RI, da Costa KA. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis 18:731-738, 1997.
22. Guo WX, Pye QN, Williamson KS, Stewart CA, Hensley KL, Kotake Y, Floyd RA, Broyles RH. Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes. Free Radic Biol Med 39:641-650, 2005.
23. Holmes-McNary MQ, Baldwin AS Jr., Zeisel, SH. Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor jB. J Biol Chem 276:41197-41204, 2001
24. Niculescu MD, Craciunescu CN, Zeisel SH. Gene expression profiling of choline-deprived neural precursor cells isolated from mouse brain. Brain Res Mol Brain Res 134:309-322, 2005.
25. Kashireddy PR, Rao MS. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood) 229:158-162, 2004.
26. Da Costa KA, Gaffney CE, Fischer LM, Zeisel SH. Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr 81:440-444, 2005.
27. Kohlmeier M, da Costa KA, Fischer LM, Zeisel SH. Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci U S A 102: 16025-16030, 2005.
28. Hoffmann K, Grafe F, Wohlrab W, Neubert RH, Brandsch M. Functional characterization of a high-affinity choline transport system in human keratinocytes. J Invest Dermatol 119:118-121, 2002.
29. Zeisel SH. Choline: an important nutrient in brain development, liver function and carcinogenesis. J Am Coll Nutr 11:473-481, 1992.
30. Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J Biol Chem 279:47402-47410, 2004.
31. Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229:988-995, 2004.
32. Ray JG, Laskin CA. Folic acid and homocystine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 20:519-529, 1999.
33. Velzing-Aarts FV, Holm PI, Fokkema MR, van der Dijs FP, Ueland PM, Muskiet FA. Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy. Am J Clin Nutr 81:1383-1389, 2005.
34. Molloy AM, Mills JL, Cox C, Daly SF, Conley M, Brody LC, Kirke PN, Scott JM, Ueland PM. Choline and homocysteine interrelations in umbilical cord and maternal plasma at delivery. Am J Clin Nutr 82: 836-842, 2005.
35. Meck WH, Williams CL. Simultaneous temporal processing is sensitive to prenatal choline availability in mature and aged rats. Neuroreport 8:3045-3051, 1997.
36. Meck WH, Williams CL. Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory. Neuroreport 8:2831-2835, 1997.
37. Meck WH, Smith RA, Williams CL. Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. Behav Neurosci 103:1234-1241, 1989.
38. Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol 160:102-109, 2004.
39. Kent C. Regulatory enzymes of phosphatidylcholine biosynthesis: a personal perspective. Biochim Biophys Acta 1733:53-66, 2005.
40. Aoyama C, Liao H, Ishidate K Structure and function of choline kinase isoforms in mammalian cells. Prog Lipid Res 43:266-281, 2004.
41. McMaster CR, Bell RM. CDP-choline:1,2-diacylglycerolcholinephospho- transferase. Biochim Biophys Acta 1348:100-110, 1997.
42. Vance JE, Vance DE. Metabolic insights into phospholipids function using gene-targeted mice. J Biol Chem 280:10877-10880, 2005.
43. Jackowski S, Fagone P. CTP:phosphocholine cytidylyltransferase: paving the way from gene to membrane. J Biol Chem 280:853-856, 2005.
44. Bakovic M, Waite K, Tang W, Tabas I, Vance DE. Transcriptional activation of the murine CTP:phosphocholine cytidylyltransferase gene (Ctpct): combined action of upstream stimulatory and inhibitory cis-acting elements. Biochim Biophys Acta 1438:147-165, 1999.
45. Golfman LS, Bakovic M, Vance DE. Transcription of the CTP: phosphocholine cytidylyltransferase alpha gene is enhanced during the S phase of the cell cycle. J Biol Chem 276:43688-43692, 2001.
46. Bakovic M, Waite K, Vance DE. Oncogenic Ha-Ras transformation modulates the transcription of the CTP:phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3. J Biol Chem 278:14753-14761, 2003.
47. Vance DE. Phosphatidylethanolamine N-methyltransferase: unexpected findings from curiosity-driven research. Eur J Med Res 1: 182-188, 1996.
48. Vance DE, Walkey CJ, Cui Z. Phosphatidylethanolamine N-methyltransferase from liver. Biochim Biophys Acta 1348:142-150, 1997.
49. Jacobs RL, Stead LM, Devlin C, Tabas I, Brosnan ME, Brosnan JT, Vance DE. Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. J Biol Chem 280:28299-28305, 2005.
50. Noga AA, Stead LM, Zhao Y, Brosnan ME, Brosnan JT, Vance DE. Plasma homocysteine is regulated by phospholipid methylation. J Biol Chem 278, 5952-5955, 2003.
51. Noga AA, Vance DE. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J Biol Chem 278:21851-21859, 2003.
52. Li Z, Agellon LB, Vance DE. Phosphatidylcholine homeostasis and liver failure. J Biol Chem 280:37798-37802, 2005.
53. Riley SP, Talbot NJ, Ahmed MJ, Jouhal K, Hendry BM. Characterization of human erythrocyte choline transport in chronic renal failure. Nephrol Dial Transplant 12:1921-1927, 1997.
54. Hendry BM. Membrane transport in uraemia. In: Raine AEG, Ed. Advanced Renal Medicine. New York: Oxford University Press, pp16-24, 1992.
55. Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 65:9369-9376, 2005.
56. Villa A, Caporizzo E, Papagni A, Miozzo L, Buttero P, Grilli M, Amboldi N, Fazio F, Doglia S, Giglioni B. Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. Eur J Cancer 41:1453-1459, 2005.
57. Wecker L. Dietary choline. A limiting factor for the synthesis of acetylcholine by the brain. Adv Neurol 51:139-145, 1990.
58. Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest 94:696-702, 1994.
59. Miller BL, Jenden DJ, Cummings JL, Read S, Rice K, Benson DF. Abnormal erythrocyte choline and influx in Alzheimer's disease. Life Sci 10:485-490, 1986.
60. Manyam BV, Giacobini E, Colliver JA. Cerebrospinal fluid choline levels are decreased in Parkinson's disease. Ann Neurol 27:683-685, 1993.
61. Manyam BV, Giacobini E, Colliver JA. Cerebrospinal fluid acetylcholine-esterase and choline measurements in Huntington's disease. J Neurol 237:281-284, 1990.
62. Barbeau A. Friedreich's ataxia 1979: an overview. Can J Neurol Sci 6: 311-319, 1979.
63. Fisher AB, Dodia C, Chander A, Kleinzeller A. Transport of choline by plasma membrane vesicles from lung-derived epithelial cells. Am J Physiol 263:C1250-C1257, 1992.
64. Deves R, Krupker RM. The binding and translocation steps in transport as related to substrate structure. A study of choline carrier of erythrocytes. Biochim Biophys Acta 557:468-485, 1979.
65. Simon JR, Atweh S, Kuhar MJ. Sodium-dependent, high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J Neurochem 26:909-922, 1976.
66. Grassl SM. Choline transport in human placental brush-border membrane vesicles. Biochim Biophys Acta 1194:203-213, 1994.
67. Porter RK, Scott JM, Brand MD. Choline transport into rat liver mitochondria. Characterization and kinetics of a specific transporter. J Biol Chem 267:14637-14646, 1992.
68. Van Rossum GDV, Boyd CAR. Sodium-dependent and -independent choline uptake by type II epithelial cells from rat lung. J Membr Biol 162:147-156, 1998.
69. Van Golde LMG. Metabolism of phospholipids in the lung. Am Rev Respir Dis 114:977-1000, 1976.
70. 14C]-choline and incorporation into lung phospholipids by the isolated rat lung. Lipids 14:555-558, 1978.
71. Yost RW, Chander A, Dodia C, Fisher AB. Synthesis of phosphatidylcholine by rat lung during choline deficiency. J Appl Physiol 61:2040-2044, 1986.
72. Klein J, Koppen A, Loffelholz K, Schmitthenner J. Uptake and metabolism of choline by rat brain after acute choline administration. J Neurochem 58:870-876, 1992.
73. Wurtman RJ. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 15:117-122, 1992.
74. Zeisel SH, Mar MH, Zhou Z, da Costa KA. Pregnancy and lactation are associated with diminished concentrations of choline and its metabolites in rat liver. J Nutr 125:3049-3054, 1995.
75. Welsch F. Choline metabolism in human term placenta. Biochem Pharmacol 27:1251-1257, 1978.
76. Müller J, Born I, Neubert RH, Brandsch M. Apical uptake of choline and cationic drugs in epithelial cell lines derived from human placenta. Placenta 26:183-189, 2005.
77. Kwon Y, Lee RD, Morris ME. Hepatic uptake of choline in rat liver basolateral and canalicular membrane vesicle preparations. J Pharmacol Exp Ther 279:774-778, 1996.
78. Sinclair CJ, Chi KD, Subramanian V, Ward KL, Green RM. Functional expression of a high affinity mammalian hepatic choline/organic cation transporter J Lipid Res 41:1841-1848, 2000.
79. Dantzler WH, Evans KK, Wright SH. Basolateral choline transport in isolated rabbit renal proximal tubules. Pflugers Arch 436:899-905, 1998.
80. Acara M. The kidney in the regulation of plasma choline in the chicken. Am J Physiol 228:645-649, 1975.
81. Nagel G, Volk C, Friedrich T, Ulzheimer JC, Bamberg E, Koepsell H. A reevaluation of substrate specificity of the rat cation ransporter rOCT1. J Biol Chem 272:31953-31956, 1997.
82. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049, 2004.
83. Ferguson SM, Blakely RD. The choline transporter resurfaces: new roles for synaptic vesicles? Mol Interv 4:22-37, 2004.
84. Sarter M, Parikh V. Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6:48-56, 2005.
85. Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher LJ. Essential role of neocortical acetylcholine in spatial memory. Nature 375:484-487, 1995.
86. Dickinson-Anson H, Winkler J, Fisher LJ, Song HJ, Pu M, Gage FH. Acetylcholine-secreting cells improve age-induced memory deficits. Mol Ther 8:51-61, 2003.
87. Warburton EC, Koder T, Cho K, Massey PV, Duguid G, Barker GRI, Aggleton JP, Bashir ZI, Brown MW. Cholinergic neurontransmission is essential for perirhinal cortical plasticity and recognition memory. Neuron 38:987-996, 2003.
88. Xie J, Guo Q. Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation to the plasma membrane. J Biol Chem 279:28266-28275, 2004.
89. Okuda T, Haga T, Kanai Y, Endou H, Ishihara T, Katsura I. Identification and characterization of the high affinity choline transporter. Nat Neurosci 3:120-125, 2000.
90. Apparsundaram S, Ferguson SM, George AL Jr, Blakely RD. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem Biophys Res Commun 276:862-867, 2000.
91. Okuda T, Haga T. Functional characterization of the human high-affinity choline tranporter. FEBS Lett 484:92-97, 2000.
92. Wang Y, Cao Z, Newkirk RF, Ivy MT, Townsel JG. Molecular cloning of a cDNA for a putative choline co-tansporter from Limulus CNS. Gene 268:123-131, 2001.
93. Apparsundaram S, Ferguson SM, Blakely RD. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem Soc Trans 29:711-716, 2001.
94. Okuda T, Haga T. High-affinity choline transporter. Neurochem Res 28:483-488, 2003.
95. Pfeil U, Haberberger RV, Lips KS, Eberling L, Grau V, Kummer W. Expression of the high-affinity choline transporter CHT1 in epithelia. Life Sci 72:2087-2090, 2003.
96. Pfeil U, Lips KS, Eberling L, Grau V, Haberberger RV, Kummer W. Expression of the high-affinity choline transporter, CHT1, in the rat trachea. Am J Respir Cell Mol Biol 28:473-477, 2003.
97. Haberberger RV, Pfeil U, Lips KS, Kummer W. Expression of the high-affinity choline transporter, CHT1, in the neuronal and non-neuronal cholinergic system of human and rat skin. J Invest Dermatol 119:943-948, 2002.
98. Barker LA. Modulation of synaptosomal high affinity choline transport. Life Sci 18:725-731, 1976.
99. Murrin LC, Kuhar MJ. Activation of high-affinity choline uptake in vitro by depolarizing agents. Mol Pharmacol 12:1082-1090, 1976.
100. Roskoski R Jr. Acceleration of choline uptake after depolarization- induced acetylcholine release in rat cortical synaptosomes. J Neurochem 30:1357-1361, 1978.
101. Sherman KA, Zigmond MJ, Hanin I. High affinity choline uptake in striatum and hippocampus: differential affects of treatments which release acetylcholine. Life Sci 23:1863-1870, 1978.
102. O'Regan S, Collier B. Factors affecting choline transport by the cat superior cervical ganglion during and following stimulation, and the relationship between choline uptake and acetylcholine synthesis. Neuroscience 6:511-520, 1981.
103. Cancela JM, Bertrand N, Beley A. Involvement of cAMP in the regulation of high affinity choline uptake by rat brain synaptosomes. Biochem Biophys Res Commun 213:944-949, 1995.
104. Volgelsberg V, Neff NH, Hadjiconstantinov M. Cyclic AMP-mediated enhancement of high-affinity choline transport and acetylcholine synthesis in brain. J Neurochem 68:1062-1070, 1997.
105. Ford BD, Ivy MT, Mtshali CP, Townsel JG. The involvement of protein kinase C in the regulation of choline cotransport in Limulus. Comp Biochem Physiol A Mol Integr Physiol 123:255-261, 1999.
106. Guyenet P, Lefresne P, Rossier J, Beaujouan JC, Glowinski J. Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. Mol Pharmacol 9:630-639, 1973.
107. Lowenstein PR, Coyle JT. Rapid regulation of [3H] hemicholinium-3 binding sites in the rat brain. Brain Res 381:191-194, 1986.
108. Cooke LJ, Rylett RJ. Inhibitiors of serine/threonine phosphatases increase membrane bound choline acetyltransferase activity and enhance acetylcholine synthesis. Brain Res 751:232-238, 1997.
109. Torres GE, Gainetdinov RR, Caron MG. Plasma membrane mono-amine transporters: structure, regulation and function. Nat Rev Neurosci. 4:13-25, 2003.
110. Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, Moscat J. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86:777-786, 1996.
111. Sells SF, Han SS, Muthukkumar S, Maddiwar N, Johnstone R, Boghaert E, Gills D, Liu G, Nair P, Monnig S, Collini P, Mattson MP, Sukhatme VP, Zimmer SG, Wood DV Jr., McRoberts JW, Shi Y, Rangnekar VM. Expression and function of the leucine zipper protein par-4 in apoptosis. Mol Cell Biol 17:3823-3832, 1997.
112. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med 4:957-962, 1994.
113. Chan SL, Tammariello SP, Estus S, Mattson MP. Prostate apoptosis response-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: actions prior to mitochondrial dysfunction and caspase activation. J Neurochem 73:502-512, 1999.
114. Mattson MP, Duan W, Chan SL, Camandola S. Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders. J Mol Neurosci 13:17-30, 1999.
115. Guo Q, Sebastian L, Sopher BL, Miller MW, Glazner GW, Ware CB, Martin GM, Mattson MP. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc Natl Acad Sci U S A 96:4125-4130, 1999.
116. Guo Q, Xie J, Chang X, Du H. Prostate apoptosis response-4 enhances secretion of amyloid β peptide 1-42 in human neuroblastomas IMR-32 cells by a caspase-dependent pathway. J Biol Chem 276:16040-16044, 2001.
117. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci U S A 101:8762-8767, 2004.
118. Jonker JW, Wagenaar E, Mol CAAM, Buitelaar M, Koepsell H, Smit JW, Schinkel AH. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of organic cation transporter 1 (Oct1[Slc 22a1]) gene. Mol Cell Biol 21:5471-5477, 2001.
119. Grundemann D, Gorboulev V, Gambaryan S, Vehyl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549-552, 1994.
120. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881, 1997.
121. Schweife N, Barlow DP. The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters. Mamm Genome 7:735-740, 1996.
122. Okuda M, Saito H, Urakami Y, Takano M, Inui K. cDNA cloing and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224:500-507, 1996.
123. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786, 1998.
124. Kakehi M, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Ohtani H, Sawada Y. Functional characterization of mouse cation transporter mOCT2 compared with mOCT1. Biochem Biophys Res Commun 296:644-650, 2002.
125. Gründemann D, Babin-Ebell J, Martel F, Örding N, Schmidt A, Schömig E. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 Cells. J Biol Chem 272:10408-10413, 1997.
126. Terashita S, Dresser MJ, Zhang L, Gray AT, Yost SC, Giacomini KM. Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochim Biophys Acta 1369:1-6, 1998.
127. Tamai I, Yabuuchai H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111, 1997.
128. Wu X, Prasad PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and genomic organizztion of human OCTn2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595, 1998.
129. Meyer-Wentrup F, Karbach U, Gorboulev V, Arndt P, Koepsell H. Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. Biochem Biophys Res Commun 248:673-678, 1998.
130. Karbach U, Kricke J, Meyer-Wentrup F, Gorboulev V, Volk C, Loffing-Cueni D, Kaissling B, Bachmann S, Koepsell H. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279:F679-F687, 2000.
131. Grundemann D, Koster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, Obermuller N, Schomig E. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 273:30915-30920, 1998.
132. Kekuda R, Prasad PD, Wu X, Wang H, Fei Y, Leibach FH, Ganapathy V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971-15979, 1998.
133. Koepsell H, Gorboulev V, Arndt P. Molecular pharmacology of organic cation transporters in kidney. J Membr Biol 167:103-117, 1999.
134. Grundemann D, Liebich G, Kiefer N, Koster S, Schomig E. Selective substrates for non-neuronal monomaine transporters. Mol Pharmacol 56:1-10, 1999.
135. Sweet DH, Miller DS, Pritchard JB. Ventricular choline transport, a role for organic cation transporter 2 expressed in choroids plexus. J Biol Chem 276:41611-41619, 2001.
136. Zhang L, Schaner ME, Giacomini KM. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 286:354-361, 1998.
137. Martel F, Vetter T, Russ H, Grundemann D, Azevedo I, Koepsell H, Schomig E. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn Schmiedebergs Arch Pharmacol 354:320-326, 1996.
138. Grundemann D, Schechinger B, Rappold GA, Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nature Neurosci 1:349-351, 1998.
139. Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, Lang F, Koepsell H. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 271:32599-32604, 1996.
140. Koehler MR, Wissinger B, Gorboulev V, Koepsell H, Schmid M. The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26. Cytogenet Cell Genet 79:198-200, 1997.
141. Koehler MR, Gorboulev V, Koepsell HM, Steinlein C, Schmid M. Roct1, a rat polyspecific transporter gene for the excretion of cationic drugs, maps to chromosome 1q11-12. Mamm Genome 7:247-248, 1995.
142. Gorboulev V, Volk C, Arndt P, Akhoundova A, Koepsell H. Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate. Mol Pharmacol 56:1254-1261, 1999.
143. Volk C, Gorboulev V, Budiman T, Nagel G, Koepsell H. Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2. Mol Pharmacol 64:1037-1047, 2003.
144. Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 23: 7902-7908, 2003.
145. Jonker JW, Schinkel AH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308:2-9, 2004.
146. Wu X, Gorge RL, Huang W, Wang H, Conway SJ, Leibach FH, Ganapathy V. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466:315-327, 2000.
147. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V. functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492, 1999.
148. Traiffort E, Ruat M, O'Regan S and Meunier FM. Molecular characterization of the family of choline transporter-like proteins and their variants. J Neurochem 92:1116-1125, 2005.
149. O'Regan S, Traiffort E, Ruat M, Cha N, Compaoré D, Meunier F. An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins. Proc Natl Acad Sci U S A 97:1835-1840, 2000.
150. Wille S, Szekeres A, Majdic O, Prager E, Staffler G, Stöckl J, Kunthalert D, Prieschl, EE, Baumruker T, Burtscher H, Zlabinger GJ, Knapp W, Stockinger H. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol 167:5795-5804, 2001.
151. Yuan Z, Wagner L, Poloumienko A, Bakovic M. Identification and expression of a mouse muscle-specific CTL1 gene. Gene 341:305-312, 2004.
152. Meunier FM, O'Regan S. Expression of CTL1 in myelinating structures of Torpedo marmorata. Neuroreport 13:1617-1620, 2002.
153. Yuan Z, Tie A, Tarnopolski M, Bakovic M. Genomic structure, expression and alternative splicing of the human choline transporter like protein. Physiol Genomics (in press), 2005.
154. +-independent choline transporter in rat astrocytes. J Neurochem. 94:1427-1437, 2005.
155. Bishop WR, Bell RM. Assembly of phospholipids into cellular membranes: biosynthesis, transmembrane movement and intracellular translocation. Annu Rev Cell Biol 4:579-610, 1988.
156. O'Regan S, Meunier FM. Selection and characterization of the choline transport mutation suppressor from Torpedo electric lobe, CTL1. Neurochem Res 28:551-555, 2003.
157. Zufferey R, Santiago TC, Brachet V, Mamoun CB. Reexamining the role of choline transporter-like (Ctlp) proteins in choline transport. Neurochem Res 29:461-467, 2004.
158. Fullerton MD, Wagner L, Yuan Z, Bakovic M. Impaired trafficking of choline transporter like protein-1 at the plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages. Am J Physiol Cell Physiol 290:C1230-C1238, 2006.
159. Fujita T, Shimada A, Okada N, Yamamoto A. Functional characterization of Na(+)-independent choline transport in primary cultures of neurons from mouse cerebral cortex. Neurosci Lett 393:216-221, 2006.
160. Novakova J, Mikasova L, Machova E, Lisa V, Dolezal V. Chronic treatment with amyloid beta(1-42) inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling. Brain Res 1062:101-110, 2005.
161. Lecomte MJ, De Gois S, Guerci A, Ravassard P, Faucon Biguet N, Mallet J, Berrard S. Differential expression and regulation of the high-affinity choline transporter CHT1 and choline acetyltransferase in neurons of superior cervical ganglia. Mol Cell Neurosci 28:303-313, 2005.
162. Vissing K, Andersen JL, Harridge SD, Sandri C, Hartkopp A, Kjaer M, Schjerling P. Gene expression of myogenic factors and phenotype-specific markers in electrically stimulated muscle of paraplegics. J Appl Physiol 99:164-172, 2005.
163. Mouly V, Aamiri A, Bigot A, Cooper RN, Di Donna S, Furling D, Gidaro T, Jacquemin V, Mamchaoui K, Negroni E, Perie S, Renault V, Silva-Barbosa SD, Butler-Browne GS. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 184:3-15, 2005.
164. Frenette J, Chbinou N, Godbout C, Marsolais D, Frenette PS. Macrophages, not neutrophils, infiltrate skeletal muscle in mice deficient in P/E selectins after mechanical reloading. Am J Physiol Regul Integr Comp Physiol 285:R727-R732, 2003.